Early versus Late Allopurinol Initiation in Acute Gout Flare (ELAG): a randomized controlled trial
Author:
Funder
navamindradhiraj university research fund
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Link
https://link.springer.com/content/pdf/10.1007/s10067-021-05872-8.pdf
Reference17 articles.
1. Pascart T, Lioté F (2019) Gout: state of the art after a decade of developments. Rheumatology (Oxford) 58(1):27–44
2. Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castañeda-Sanabria J et al (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76(1):29–42
3. Hui M, Carr A, Cameron S, Davenport G, Doherty M, Forrester H et al (2017) The British Society for Rheumatology guideline for the management of gout. Rheumatology (Oxford) 56(7):1056–1059
4. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM et al (2020) 2020 American College of Rheumatology guideline for the management of gout. Arthritis Care Res (Hoboken) 72(6):744–760
5. Hill EM, Sky K, Sit M, Collamer A, Higgs J (2015) Does starting allopurinol prolong acute treated gout? A randomized clinical trial. J Clin Rheumatol 21(3):120–125
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. La gota, más allá de la articulación: ¿cómo debemos tratarla?;Medicina de Familia. SEMERGEN;2024-07
2. An updated systematic review and meta-analysis of randomised controlled trials on the effects of urate-lowering therapy initiation during a gout flare;Seminars in Arthritis and Rheumatism;2024-04
3. CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy;Annals of Hematology;2023-11-02
4. Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flares;Rheumatology;2023-10-31
5. Efficacy of initiating urate-lowering therapy during an acute gout episode: a meta-analysis;Zeitschrift für Rheumatologie;2023-05-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3